Postmenopausal - PowerPoint PPT Presentation


Understanding Uterine Cancer and Postmenopausal Bleeding

Dr. Khalid Akkour, Assistant Professor of Gynecologic Oncology at King Saud University Medical City, provides insights on uterine cancer and postmenopausal bleeding. The structured OSCE discusses important aspects such as taking a focused history, age, ethnicity, past gynecologic and obstetric histo

0 views • 154 slides


Updated IMS Recommendations on Postmenopausal Hormone Therapy and Preventive Strategies

The 2011 revision of the IMS Recommendations provides an insightful view on hormone replacement therapy (HRT) for peri- and postmenopausal women. It emphasizes the need for individualized treatment, considering lifestyle factors and clear indications for HRT use. Special attention is given to women

0 views • 60 slides



Recommendations for Screening Adherence to Oral Bisphosphonates in Osteoporosis

The International Osteoporosis Foundation and European Calcified Tissue Society Working Group provides recommendations for screening adherence to oral bisphosphonates in osteoporosis. Low adherence to bisphosphonates can lead to reduced efficacy and cost-effectiveness in treating osteoporosis. The w

0 views • 18 slides


Extended Endocrine Therapy Guidelines for Breast Cancer Patients

Extended adjuvant endocrine therapy may benefit breast cancer patients with poor or intermediate prognosis, but may have little value for those with good prognosis. Risks include osteoporosis and venous thromboembolism. Different treatment options are available for postmenopausal and premenopausal w

0 views • 9 slides


Thermal Treatment of Vulvo-vaginal Atrophy Using Dynamic Quadripolar Radiofrequency

Evaluating the safety and efficacy of Dynamic Quadripolar Radiofrequency treatment for Vulvo-vaginal Atrophy (VVA) in postmenopausal women who cannot or prefer not to use hormone therapy. The study compares treatment outcomes of radiofrequency therapy with a control group using pH cream, focusing on

0 views • 6 slides


Therapies and Strategies for ER-Positive, HER2-Negative Metastatic Breast Cancer

Explore the selection and sequence of therapy for ER-positive, HER2-negative metastatic breast cancer, along with novel agents and strategies under evaluation. Learn about cases of postmenopausal women with metastatic breast cancer, CDK4/6 inhibitors, and the impact of targeted therapies on patient

0 views • 23 slides